Drug-induced sclerosing peritonitis
- PMID: 264629
Drug-induced sclerosing peritonitis
Abstract
The records and case reports of 20 patients presenting with practolol induced sclerosing peritonitis have been reviewed revealing striking similarities: symptoms and signs of bowel obstruction or the presence of a vague abdominal mass in a patient who is currently taking or has previously taken practolol should alert one to the possibility of sclerosing peritonitis as the cause. Skin or eye reactions attributed to practolol provide further strong support for the diagnosis. Although practolol has now been discontinued in New Zealand its effects may become manifest months or years later.
Similar articles
-
Sclerosing peritonitis and practolol therapy.Ann R Coll Surg Engl. 1976 Nov;58(6):473-5. Ann R Coll Surg Engl. 1976. PMID: 984691 Free PMC article.
-
Sclerosing peritonitis due to practolol.Br Med J. 1977 May 28;1(6073):1393-4. doi: 10.1136/bmj.1.6073.1393. Br Med J. 1977. PMID: 861650 Free PMC article.
-
Sclerosing encapsulating peritonitis: differential diagnosis to peritoneal encapsulation and abdominal cocoon--a case report.Z Gastroenterol. 1992 Aug;30(8):534-7. Z Gastroenterol. 1992. PMID: 1413936
-
Problems in the surgical management of sclerosing encapsulating peritonitis.Isr J Med Sci. 1993 Nov;29(11):686-8. Isr J Med Sci. 1993. PMID: 8270396 Review.
-
Intestinal obstruction due to idiopathic sclerosing encapsulating peritonitis. Clinical report and review of literature.G Chir. 2008 Apr;29(4):173-6. G Chir. 2008. PMID: 18419984 Review.